Search

everythinglearnresearchcommunity

for

Search:↓

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Small molecule treatments improve the ability of human amniotic fluid stem cells to become different cell types.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Restoring microbial balance and using exosome therapies may help treat hair disorders like alopecia and acne.

Nanotechnology shows promise for treating hair loss but faces safety and approval challenges.

Topical treatments like AHAs, BHAs, and urea may help keratosis pilaris, but evidence is limited.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Ivermectin with supportive therapies effectively treats canine demodicosis.

Nanomaterials like silver and gold can improve wound healing but need more research for safety.

Nanomaterials in wound dressings help fight infections and improve healing.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

Cronkhite-Canada syndrome can be diagnosed without gastrointestinal polyps if there is severe mucosal atrophy and edema.

Early treatment with corticosteroids and immunosuppressants is crucial for managing Vogt-Koyanagi-Harada disease.

The comprehensive treatment with biomimetic peptide lotion was effective for hair loss.

The formulation significantly increased hair density and thickness safely in people with androgenetic alopecia.

Collagen supplements may improve skin, joints, and recovery, especially with added nutrients.

Certain fungi protect skin health, but changes can allow harmful fungi to cause serious infections, needing more research for treatment and control.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.

Endocrine therapies for cancer significantly increase the risk of hair loss.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Light affects skin health, aging, and cancer risk, and new light-based treatments and imaging are promising for skin care.

Exosome-based therapies in dermatology show promise but face challenges in standardization, regulation, and safety.